153 related articles for article (PubMed ID: 23471065)
1. Patent landscaping for life sciences innovation: toward consistent and transparent practices.
Bubela T; Gold ER; Graff GD; Cahoy DR; Nicol D; Castle D
Nat Biotechnol; 2013 Mar; 31(3):202-6. PubMed ID: 23471065
[No Abstract] [Full Text] [Related]
2. How Indian biotech is driving innovation.
Nogrady B
Nature; 2018 Dec; 564(7735):S53-S55. PubMed ID: 30542184
[No Abstract] [Full Text] [Related]
3. Companies balk at California's patent rules for stem cell research.
Keim B
Nat Med; 2007 Jan; 13(1):6. PubMed ID: 17206112
[No Abstract] [Full Text] [Related]
4. Among the best.
Jayaraman KS
Nature; 2005 Jul; 436(7050):492-5. PubMed ID: 16049476
[No Abstract] [Full Text] [Related]
5. Brokering knowledge in biosciences with InnoCentive. Interview by Semahat S. Demir.
Hussein A
IEEE Eng Med Biol Mag; 2003; 22(4):26-7. PubMed ID: 14515687
[No Abstract] [Full Text] [Related]
6. Biomedical research and the commercialization agenda: a review of main considerations for neuroscience.
Caulfield T; Ogbogu U
Account Res; 2008; 15(4):303-20. PubMed ID: 18972268
[TBL] [Abstract][Full Text] [Related]
7. The innovation value chain of patents: Breakthrough in the patent commercialization trap in Chinese universities.
Gong H; Nie L; Peng Y; Peng S; Liu Y
PLoS One; 2020; 15(3):e0230805. PubMed ID: 32214371
[TBL] [Abstract][Full Text] [Related]
8. Cuba--innovation through synergy.
Thorsteinsdóttir H; Sáenz TW; Quach U; Daar AS; Singer PA
Nat Biotechnol; 2004 Dec; 22 Suppl():DC19-24. PubMed ID: 15583679
[No Abstract] [Full Text] [Related]
9. Advancing innovation through R&D the A∗STAR way.
Poh LC
Biointerphases; 2010 Sep; 5(3):FA3-8. PubMed ID: 21171710
[No Abstract] [Full Text] [Related]
10. Don't feed the trolls.
Nature; 2014 Jun; 510(7503):7. PubMed ID: 24910865
[No Abstract] [Full Text] [Related]
11. Industrial Biotechnology: To What Extent Is Responsible Innovation on the Agenda?
Rosemann A; Molyneux-Hodgson S
Trends Biotechnol; 2020 Jan; 38(1):5-7. PubMed ID: 31399264
[TBL] [Abstract][Full Text] [Related]
12. Expanding the innovation pool.
Nat Biotechnol; 2012 Oct; 30(10):897. PubMed ID: 23051787
[No Abstract] [Full Text] [Related]
13. Bioscience in the sun.
Russo G
Nature; 2007 Apr; 446(7139):1112-3. PubMed ID: 17506174
[No Abstract] [Full Text] [Related]
14. The performance of China's biomedical innovation: a scientometric analysis.
Tang X; Du J
Sci China Life Sci; 2016 Oct; 59(10):1074-1082. PubMed ID: 27437700
[No Abstract] [Full Text] [Related]
15. Patents and innovation in cancer therapeutics: lessons from CellPro.
Bar-Shalom A; Cook-Deegan R
Milbank Q; 2002; 80(4):637-76, iii-iv. PubMed ID: 12532643
[TBL] [Abstract][Full Text] [Related]
16. Academic freedom and academic-industry relationships in biotechnology.
Streiffer R
Kennedy Inst Ethics J; 2006 Jun; 16(2):129-49. PubMed ID: 17036444
[TBL] [Abstract][Full Text] [Related]
17. Life sciences venture capital in emerging markets.
Chakma J; Sammut SM; Agrawal A
Nat Biotechnol; 2013 Mar; 31(3):195-201. PubMed ID: 23471064
[No Abstract] [Full Text] [Related]
18. Do patents of academic funded researchers enjoy a longer life? A study of patent renewal decisions.
Tahmooresnejad L; Beaudry C
PLoS One; 2018; 13(8):e0202643. PubMed ID: 30157218
[TBL] [Abstract][Full Text] [Related]
19. Legal and social aspects of biotechnology in Poland.
Twardowski T
Acta Biochim Pol; 2005; 52(3):III-V. PubMed ID: 16475253
[No Abstract] [Full Text] [Related]
20. Medical device research.
Boyle J; Maeder A; Bell J; John S; Scott R
Expert Rev Med Devices; 2005 Jan; 2(1):41-5. PubMed ID: 16293027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
